The prime objective of the Scheme is to achieve long term capital appreciation by investing
in a portfolio consisting of equity and equity related securities predominantly of mid cap
companies.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Mid Cap Fund | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -2.25% | 3.39% | 8.08% | 6.71% | 3.05% | -0.45% | 8.29% | 13.95% | 9.88% | 13.46% | 8.19% |
| Category returns | -5.85% | -4.69% | 0.92% | 2.35% | 0.08% | -0.26% | 13.48% | 15.57% | 11.95% | 14.28% | N/A |
| Absolute returns | -2.25% | 3.39% | 8.08% | 6.71% | 3.05% | -0.91% | 27.02% | 68.67% | 60.19% | 253.53% | 1156.4% |
| Rank within category | 1/34 | 1/33 | 1/33 | 5/31 | 4/31 | 14/29 | 27/29 | 22/27 | 20/25 | 14/20 | N/A |
| Mid Cap Fund | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Yearly returns | 3.21% | 46.13% | -7.01% | 1.61% | 25.53% | 32.67% | 6.74% | 38.38% | 11.32% | 0.77% | 4.54% |
| Q1 returns | -8.61% | 17.31% | -3.28% | 2.05% | -19.52% | 11.32% | 0.34% | -7.23% | 1.78% | -9.71% | -14.79% |
| Q2 returns | 11.39% | 6.3% | -1.01% | -2.74% | 19.34% | 12.91% | -11.24% | 21.25% | 13.86% | 15.82% | 14.38% |
| Q3 returns | 10.74% | 5.19% | -4.67% | -2.49% | 14.37% | 7.99% | 14.02% | 12.31% | 4.79% | -4.11% | 8.06% |
| Q4 returns | -8.45% | 11.41% | 1.88% | 4.99% | 14.28% | -2.26% | 5.1% | 9.54% | -8.33% | 0.48% | -0.73% |
1% on or before 365D, Nil after 365D
| Alpha | -0.297361 |
| Beta | 0.9127 |
| Sharpe Ratio | 0.0828971 |
| Sortino Ratio | 0.154979 |
| R-Squared | 0.8577 |
| Tracking Error | 1.7989 |
| Downside Risk | 23.9618 |
| Std. Deviation (Annualised) | 16.2069 |
| Mid Cap Fund | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSBC Midcap Fund - Regular Plan - Growth | -6.62% | -2.36% | 6.43% | 12.63% | 9.64% | 19.71% | 15.17% | 15.18% | 18.61% | 16,799.60 | 2.21 | 0.24 | Very High |
| Invesco India Midcap Fund - Regular Plan - Growth | -6.16% | -6.58% | 3.36% | 4.07% | -0.27% | 19.62% | 15.34% | 16.73% | 16.13% | 15,748.80 | 1.88 | 0.24 | Very High |
| WhiteOak Capital Mid Cap Fund - Regular Plan - Growth | -5.13% | -3.48% | 4.47% | 6.01% | 5.01% | 17.95% | N/A | N/A | 19.6% | 7,539.96 | 2.26 | 0.24 | Very High |
| ICICI Prudential Mid Cap Fund - Growth | -7.36% | -5.65% | -3.24% | 2.74% | 3.82% | 17.75% | 13.62% | 14.66% | 17.03% | 7,960.87 | 1.85 | 0.23 | Very High |
| Edelweiss Mid Cap Fund - Regular Plan - Growth | -5.43% | -5.03% | -0.61% | -0.02% | -0.12% | 17.3% | 14.22% | 16.45% | 13.14% | 19,230.20 | 1.87 | 0.22 | Very High |
| Motilal Oswal Midcap Fund - Regular Plan - Growth | -5.16% | -0.63% | 6.16% | 1.34% | -5.95% | 16.1% | 17.2% | 15.17% | 19.81% | 40,207.50 | 1.64 | 0.18 | Very High |
| ITI Mid Cap Fund - Regular Plan - Growth | -6.97% | -5.91% | -0.62% | -0.6% | 0.41% | 15.39% | 12.08% | N/A | 14.66% | 1,452.83 | 2.42 | 0.19 | Very High |
| Nippon India Growth Mid Cap Fund - Growth Option | -5.21% | -5.29% | -2.09% | 1.47% | 0.45% | 15.18% | 14.42% | 16.32% | 21.51% | 50,176.00 | 1.55 | 0.19 | Very High |
| Sundaram Mid Cap Fund - Regular Plan - Growth | -6.37% | -6.78% | -2.29% | -0.87% | -1.96% | 14.86% | 13.41% | 12.46% | 22.57% | 13,854.10 | 1.86 | 0.19 | Very High |
| Taurus Mid Cap Fund - Regular Plan - Growth Current | -2.25% | 3.39% | 8.08% | 6.71% | 3.05% | 8.29% | 9.88% | 13.46% | 8.19% | 137.54 | 2.80 | 0.08 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sigma Advanced Systems Ltd. | Aerospace & Defense | Domestic Equities | 10.71% |
| Persistent Systems Ltd. | IT - Software | Domestic Equities | 5.38% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.97% |
| Linde India Ltd. | Chemicals & Petrochemicals | Domestic Equities | 4.67% |
| Coforge Ltd. | IT - Software | Domestic Equities | 4.66% |
| GE Vernova T&D India Ltd. | Electrical Equipment | Domestic Equities | 4.54% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.34% |
| The Federal Bank Ltd. | Banks | Domestic Equities | 4.23% |
| The Indian Hotels Company Ltd. | Leisure Services | Domestic Equities | 3.98% |
| Net Receivable / Payable | Cash & Cash Equivalents and Net Assets | 3.79% | |
| Skyways Air Services Ltd. | Transport Services | Domestic Equities | 3.60% |
| GMR Airports Ltd. | Transport Infrastructure | Domestic Equities | 3.11% |
| REC Ltd. | Finance | Domestic Equities | 2.74% |
| Hindustan Copper Ltd. | Non - Ferrous Metals | Domestic Equities | 2.41% |
| Mphasis Ltd. | IT - Software | Domestic Equities | 2.35% |
| Advit Jewels Ltd. | Consumer Durables | Domestic Equities | 2.29% |
| PI Industries Ltd. | Fertilizers & Agrochemicals | Domestic Equities | 2.26% |
| Bank Of India | Banks | Domestic Equities | 2.18% |
| Mazagon Dock Shipbuilders Ltd. | Industrial Manufacturing | Domestic Equities | 2.15% |
| Pranav Constructions Ltd. | Realty | Domestic Equities | 2.05% |
| Insolation Energy Ltd. | Electrical Equipment | Domestic Equities | 1.94% |
| Oswal Pumps Ltd. | Industrial Products | Domestic Equities | 1.94% |
| Balkrishna Industries Ltd. | Auto Components | Domestic Equities | 1.86% |
| Veegaland Developers Ltd. | Realty | Domestic Equities | 1.85% |
| Dabur India Ltd. | Personal Products | Domestic Equities | 1.66% |
| PB Fintech Ltd. | Financial Technology (Fintech) | Domestic Equities | 1.55% |
| Samhi Hotels Ltd. | Leisure Services | Domestic Equities | 1.51% |
| Dalmia Bharat Ltd. | Cement & Cement Products | Domestic Equities | 1.47% |
| Havells India Ltd. | Consumer Durables | Domestic Equities | 1.33% |
| Ceigall India Ltd. | Construction | Domestic Equities | 1.21% |
| Ahluwalia Contracts (India) Ltd. | Construction | Domestic Equities | 1.20% |
| Multi Commodity Exchange Of India Ltd. | Capital Markets | Domestic Equities | 1.08% |
| Bharat Dynamics Ltd. | Aerospace & Defense | Domestic Equities | 0.97% |
| Xtranet Technologies Ltd. | IT - Services | Domestic Equities | 0.82% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.81% |
| MRF Ltd. | Auto Components | Domestic Equities | 0.73% |
| Dixon Technologies (India) Ltd. | Consumer Durables | Domestic Equities | 0.72% |
| Bharat Heavy Electricals Ltd. | Electrical Equipment | Domestic Equities | 0.60% |
| A-One Steels India Ltd. | Industrial Products | Domestic Equities | 0.34% |
| Total | 100.00% | ||
He has overall experience of 17 years in Managing wealth management and handling Risk Management Process for various Corporates. He worked with Religare Securities Ltd. as AVP - Risk & operations, FCH Centrum Wealth Managers Ltd. as Manager-Risk and in Priviwealth Pvt. Ltd. as Head of Research.
Mr. Srivastava has 12+ years of experience in the Indian equity markets. He has worked as the Head of Research and Co-Fund Manager in Kaizen Asset Management (FPI). Before this, he worked with Dal Investments (Family Office) asHead of Research. Prior to that, he has also worked as Head of Research in quant Money Manager & Lead Sector Analyst in Quant Capital, KR Choksey, Elara Capital & Bonanza Portfolio.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
